迈威生物公告，公司通过上海证券交易所交易系统以集中竞价交易方式累计回购股份20.21万股，占公 司总股本比例为0.05%，累计已回购金额为1069.46万元，实际回购价格区间为50元/股至58.02元/股。此 次回购股份将用于员工持股计划或股权激励，回购资金总额预计在2500万元至5000万元之间。 ...

Core Points - The company has repurchased a total of 3.2025 million shares, representing 0.83% of its total share capital [1] - The total amount spent on the share repurchase is 80.0216 million yuan [1] - The actual repurchase price range is between 23.5 yuan per share and 25.85 yuan per share [1] - The repurchased shares will be used for employee stock ownership plans or equity incentives [1] - The total repurchase fund is set to be no less than 80 million yuan and no more than 160 million yuan [1]

Group 1 - The company announced a share repurchase plan with a total expected amount of 500 million to 960 million yuan, aimed at employee stock ownership plans or equity incentives [1] - The implementation period for the repurchase plan is from August 28, 2025, to August 27, 2026 [1] - On September 17, the company repurchased 3.36 million shares, accounting for 0.07% of the total share capital, at a payment amount of 24.81 million yuan, with a repurchase price range of 7.28 to 7.45 yuan per share [1] Group 2 - To enhance capital efficiency, the company received a loan commitment letter from Agricultural Bank of China Ningbo Mingzhou Branch on September 9 [1] - The company has recently completed the establishment of a dedicated securities account for the repurchase loan, while other details of the repurchase plan remain unchanged [1] - The company will implement the repurchase in accordance with regulations and disclose information in a timely manner [1]

百傲化学（603360）公告，2025年7月29日，公司通过集中竞价方式首次回购公司股份26.79万股，占公 司总股本的比例为0.04%，回购的最高价为人民币20.22元/股，回购的最低价为人民币20.18元/股，回购 的资金总额为人民币541.31万元(不含交易费用)。本次回购股份用于员工持股计划或股权激励，回购资 金总额不低于人民币2亿元，不超过人民币4亿元。 ...

新坐标（603040）公告，公司于2025年4月16日首次通过集中竞价交易方式回购股份，回购35.68万股， 占公司总股本的0.2614%，回购价格区间为23.89元/股至24.7元/股，已支付的总金额为874.39万元(不含 交易费用)。本次回购符合相关法律法规及公司回购股份方案的要求，回购股份将用于实施员工持股计 划或股权激励。 ...